We also show that LBP levels were significantly increased in active compared to inactive patients, that they correlated with disease severity, and that loss of gut integrity in RA is partially corrected in etanercept (TNF-α inhibitor)-treated patients. This evidence concerns the gene TNF and rheumatoid arthritis.